Açıklama
Bioavailability challenges and delivery strategies for curcumin, addressing the compound's poor oral absorption that limits its clinical inflammasome-targeting potential.
Cite This Figure
![Figure 6: Bioavailability challenges and delivery strategies for curcumin, addressing the compound's poor oral absorption that limits its clinical inflammasome-targeting potential.]() > Source: Tarek Benameur et al. "The Effects of Curcumin on Inflammasome: Latest Update.." *Molecules (Basel, Switzerland)*, 2023. PMID: [36677800](https://pubmed.ncbi.nlm.nih.gov/36677800/)
<figure> <img src="" alt="Bioavailability challenges and delivery strategies for curcumin, addressing the compound's poor oral absorption that limits its clinical inflammasome-targeting potential." /> <figcaption>Figure 6. Bioavailability challenges and delivery strategies for curcumin, addressing the compound's poor oral absorption that limits its clinical inflammasome-targeting potential.<br> Source: Tarek Benameur et al. "The Effects of Curcumin on Inflammasome: Latest Update.." <em>Molecules (Basel, Switzerland)</em>, 2023. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/36677800/">36677800</a></figcaption> </figure>